RAD001 for Patients With Radioiodine Refractory Thyroid Cancer
Clinical trial NCT00936858 · COMPLETED
Trial details
- NCT number
- NCT00936858
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2020-02-27
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.